What Trump’s New Drug Pricing Deal Means for People With Obesity
The president’s agreement with drug companies involves a range of [...]
The president’s agreement with drug companies involves a range of [...]
Regulators sent about 100 warning letters this week to drug [...]
The administration is proposing a return to a 1990s-era policy [...]
The administration has not put forward a clear legal authority [...]
A loophole in Trump’s policy bill would continue to encourage [...]
CVS Caremark decided to stop offering Zepbound in favor of [...]
After taking part in a landmark case against the manufacturers [...]
Eli Lilly reported promising results from a study of its [...]
U.S. regulators are trying to shut down the industry for [...]
Levies on Americans’ daily prescriptions and other medicines could raise [...]